Table 2 Summary of findings—direct costs, hospitalisation rates and indirect costs.
From: The clinical and economic burden of obesity in low- and middle-income countries: a systematic review
Study | Year of costing | Main findings (costs inflated 2024 US$) | Comments |
---|---|---|---|
Kudel et al. [30] | 2015 | Physician costs (obesity class I, US$159.8) and obesity class II (US$180.34), obesity class III (US$188.14)) Hospitalisation costs (obesity class I (US$840.2), obesity class II (US$933.9), and obesity class III (US$1839.7)) Indirect cost (obesity class I (US$582), obesity class II (US$867.8) and obesity class III (US$970.2) | Hospitalisation costs were over twice as high and indirect costs were nearly double for obesity class III than for normal BMI respondents. |
Bahia et al. [33] | 2010 | Hospitalisation costs = US$ 1566.9 million); Ambulatory costs (medical visits, exams, procedures) = US$ 701.1 million; Total costs = US$ 2.2 billion | Obesity attributable hospitalisation costs were higher among men, although population-attributable risk (PAR) was lower than in women. The inverse situation was seen regarding outpatient costs, with much higher PAR but lower costs among men. |
de Oliveira et al. [37] | 2011 | Direct costs attributable to obesity, US$ 544 million The cost of morbid obesity, US$ 129.5 million; Bariatric surgery costs in Brazil total US$ 35.11 million | The cost of morbid obesity in women was five times higher than it was in men. The highest costs attributable to morbid obesity were for ischemic heart disease and diabetes. |
Pitayatienanan et al. [32] | 2009 | The direct health care cost attributable to obesity was estimated at US$193.3 million or 1.5% of national health expenditure. The cost of productivity loss attributable to obesity was estimated at US$227.5 million- accounting for 54% of the total cost of obesity. | Costs associated with health care provision and costs associated with productivity loss were broadly similar. |
Canella et al. [39] | 2009 | Monthly household expenses on medicines per capita in households with obesity was US$ 46.8 Public Sector expenses per capita (obtained in the SUS) = US$9.2 Private Sector (paid for out-of-pocket) per capita = US$37.1 | Out-of-pocket expenses on medicines were always higher than the cost of medicines obtained through the public sector. |
Sichieri et al. [41] | N/A | Average length of stay (days), M = 7.9; Women = 6.8 Hospitalisation rate attributable to obesity for men (37.5) and for women (130.8). | Diseases associated with obesity had a significant impact on hospitalisations and economic costs in Brazil. |
Ramezankhani et al. [42] | N/A | Total number of hospitalisation/number of person-years (M = 803/9207, W = 2354/25,173 | Obesity was associated with increased hospitalisation rates during long-term follow-up. |
Lartey et al. [34] | 2017 | Female: Out of Pocket Costs = US$ 2,021.2 National Health Insurance = US$3,508 Total costs = US$5530 (95% CI: 5,493.6 to 5568) Male, Out of Pocket costs = US$1,801 (1785-1814.5) National Health Insurance = US$3,124 (3097.6–3148) Total costs = US$4,923 (4885 – 4963) | Obesity is associated with significantly higher healthcare costs, with these effects being higher in females. |
Li et al. [31] | 2015 | Direct cost = US$3,774million Indirect costs = US$203 million | Direct expense comprised the biggest constituent of total costs, accounting for more than 90% of costs, and hospitalisation was the largest driver of direct medical costs. Males had higher direct costs and higher overall disease expenses than females. |
Rtveladze et al. [38] | 2010 & 2050 | The health care costs will double from US$12.56 billion (2010) to US$23.8 billion (2050). | Relatively small reductions in the level of BMI can lead to substantial disease reduction and cost savings for the health care system. |
Rtveladze et al. [40] | 2000 | Costs of US$1,445.3 million are estimated for 2010, projected to increase to US$ 2.15 billion and US$ 3.04 billion in 2030 and 2,050, respectively | A 1% reduction in BMI prevalence could save US$ 43 million in healthcare costs in 2030 and US$ 85 million in 2050. |
Boachie et al. [35] | 2020 | Total costs per patients ranges US$1,763 million to US$2,085 million | The main driver of obesity cost (approximately 91%) were coming from hypertension and diabetes. |
Shi et al. [36] | 2011 | Annual total direct health care costs = RMB 2,050.68) Annual outpatient costs (RMB 587.68) Annual inpatient costs (RMB 302.70) Annual self-health care costs (RMB 1,160.31) | Patients with obesity had significantly higher total direct health care costs compared with the normal-weight group. |